Androgenetic Alopecia

Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, Eirion Therapeutics announced in a press release.

The first patients have been dosed in a phase 2a clinical trial of PP405 for the treatment of androgenetic alopecia, Pelage Pharmaceuticals announced in a press release.

Prescribers have expressed an overall positive opinion toward the off-label use of low-dose oral minoxidil for the treatment of androgenetic alopecia, though opinions varied based on years of experience, according to a study.

In this Healio exclusive video, Ronda S. Farah, MD, FAAD, discusses surgical and nonsurgical technologies for comprehensive hair restoration that she highlighted during a session at the American Academy of Dermatology Annual Meeting.

A study discussing a novel, botanical serum for the treatment of androgenetic alopecia was the most popular article on the Healio Dermatology website this year.

Platelet-rich plasma therapy may be more effective than minoxidil in treating androgenetic alopecia, according to a study.

In this edition, novel serum improves hair growth in androgenetic alopecia; cardiovascular disease linked to dermatological inflammatory diseases; sugary drinks may be associated with male pattern hair loss and more.

Revivv, a novel topical serum, led to meaningful improvements in hair growth with no adverse events in patients with androgenetic alopecia, according to a study.

Patients with androgenetic alopecia demonstrated improvements in hair follicle growth and density after treatment with topical melatonin, according to a study.